Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial

Autor: Humrich, Jens Y *, von Spee-Mayer, Caroline, Siegert, Elise, Bertolo, Martina, Rose, Angelika, Abdirama, Dimas, Enghard, Philipp, Stuhlmüller, Bruno, Sawitzki, Birgit, Huscher, Dörte, Hiepe, Falk, Alexander, Tobias, Feist, Eugen, Radbruch, Andreas, Burmester, Gerd-Rüdiger, Riemekasten, Gabriela
Zdroj: In The Lancet Rheumatology September 2019 1(1):e44-e54
Databáze: ScienceDirect